Transcatheter Heart Valves

Transcatheter Heart Valves


Global Transcatheter Heart Valves Market to Reach US$43.6 Billion by 2030

The global market for Transcatheter Heart Valves estimated at US$15.1 Billion in the year 2023, is expected to reach US$43.6 Billion by 2030, growing at a CAGR of 16.3% over the analysis period 2023-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$31.4 Billion by the end of the analysis period. Growth in the Transcatheter Mitral Valve (TMV) segment is estimated at 15.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.9 Billion While China is Forecast to Grow at 20.9% CAGR

The Transcatheter Heart Valves market in the U.S. is estimated at US$3.9 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.1 Billion by the year 2030 trailing a CAGR of 20.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 13.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

Global Transcatheter Heart Valves Market - Key Trends and Drivers Summarized

What Makes Transcatheter Heart Valves a Game-Changing Advancement in Cardiology?

Transcatheter heart valves represent a groundbreaking advancement in the field of cardiology, offering a minimally invasive alternative to traditional open-heart surgery for patients suffering from severe heart valve diseases such as aortic stenosis. Unlike conventional surgical valve replacement procedures that require a large chest incision and a heart-lung machine, transcatheter heart valve procedures involve the insertion of a collapsible valve via a catheter, typically through a small incision in the groin or chest. Once in place, the valve expands and starts functioning immediately, restoring normal blood flow without the need for open-heart surgery. This approach significantly reduces the physical trauma and recovery time associated with traditional surgery, making it a viable option for elderly patients or those with high surgical risk who may not be candidates for conventional procedures. The primary technology in this field is Transcatheter Aortic Valve Replacement (TAVR), which has gained widespread adoption due to its proven efficacy and lower complication rates compared to surgical options. The success of TAVR has spurred the development of transcatheter solutions for other heart valves, including the mitral and tricuspid valves, expanding the therapeutic scope of transcatheter valve interventions. With shorter hospital stays, reduced postoperative pain, and faster recovery times, transcatheter heart valves are not only improving patient outcomes but are also transforming the standard of care in cardiovascular treatment.

How Are Innovations in Transcatheter Heart Valves Shaping the Future of Cardiac Care?

The field of transcatheter heart valves is witnessing rapid innovation, driven by advancements in material science, device design, and procedural techniques, which are enhancing the safety, efficacy, and versatility of these life-saving devices. One of the most significant innovations is the development of next-generation transcatheter valves that offer enhanced durability and adaptability to complex anatomies. These new devices incorporate advanced materials such as nitinol—a shape-memory alloy that allows the valves to be self-expanding and more conformable to the patient’s anatomy, ensuring a better fit and reducing the risk of leaks or complications. Another key innovation is the use of tissue-engineered and bioresorbable valve components, which aim to improve the long-term performance of the devices and minimize the risk of calcification. Furthermore, new delivery systems and smaller catheter sizes are making it possible to perform these procedures with even less trauma, allowing access through smaller vessels and further reducing the risk of vascular complications. Innovations in imaging technology, such as 3D echocardiography and CT-guided navigation, are also enhancing procedural precision, enabling more accurate placement of the valve and reducing the risk of complications. The integration of digital health technologies is another major trend, with some devices incorporating sensors and wireless monitoring systems that provide real-time data on valve performance and patient health, allowing for proactive management and timely interventions.

What Challenges Are Affecting the Adoption and Development of Transcatheter Heart Valves?

Despite their transformative potential, the adoption and development of transcatheter heart valves face several significant challenges that need to be addressed to optimize their use and expand their reach. One of the primary challenges is the high cost associated with these procedures. Transcatheter valve replacement, particularly TAVR, is a resource-intensive process that involves expensive devices, specialized training, and sophisticated imaging and procedural equipment, which can limit accessibility, especially in low-income and rural settings. Another challenge is the complexity of patient selection and procedural planning. Unlike traditional surgical valve replacement, which is performed under direct visualization, transcatheter procedures rely heavily on imaging modalities such as echocardiography, CT scans, and fluoroscopy to guide valve placement. This demands a high level of expertise and precise anatomical assessment, making the learning curve steep for new operators and complicating the integration of these procedures into less experienced centers. Additionally, the long-term durability of transcatheter heart valves remains a concern, especially for younger patients who may outlive the lifespan of the device. Although newer materials and designs are aimed at extending durability, data on long-term outcomes beyond 10-15 years is still limited, making it difficult to determine the optimal patient profile for these procedures. The risk of complications, such as paravalvular leak, valve thrombosis, or vascular damage during catheter insertion, also poses challenges that can impact patient outcomes. Regulatory hurdles and reimbursement issues also complicate the landscape, as the approval and reimbursement criteria for transcatheter devices are often vary significantly between regions.

What Factors Are Driving Growth in the Transcatheter Heart Valve Market?

The growth in the transcatheter heart valve market is driven by several factors, including the rising prevalence of cardiovascular diseases, an aging global population, and technological advancements in device design and procedural techniques. One of the primary drivers is the increasing incidence of aortic stenosis and other valvular heart diseases, particularly among the elderly, who are often at higher surgical risk and thus more likely to benefit from minimally invasive transcatheter options. As the global population ages, the demand for less invasive treatments that offer faster recovery and fewer complications is rising, making transcatheter heart valves an increasingly preferred choice. Another key driver is the expansion of clinical indications for these devices. Originally approved for high-risk surgical candidates, transcatheter valve replacement procedures are now being performed in lower-risk patients, following clinical trials that demonstrated comparable or superior outcomes to surgical valve replacement. This broadening of indications is significantly expanding the patient pool eligible for these treatments, driving market growth. Technological advancements are also propelling the market, with innovations such as repositionable and retrievable valves, smaller delivery systems, and advanced imaging tools that are making the procedures safer and more effective. Furthermore, the growing adoption of heart team approaches—where cardiologists, surgeons, and imaging specialists collaborate to determine the best treatment plan—has improved patient selection and procedural outcomes, enhancing the overall success rate of transcatheter interventions. The rise of dedicated transcatheter valve programs in hospitals around the world, supported by specialized training and educational initiatives, is also contributing to market growth by building the necessary infrastructure and expertise. Lastly, increasing awareness of the benefits of transcatheter heart valves, coupled with favorable reimbursement policies in several regions, is making these procedures more accessible and driving higher adoption rates. These factors collectively indicate a robust growth trajectory for the transcatheter heart valve market, positioning it as a key component of interventional cardiology.

Select Competitors (Total 16 Featured) -
  • Boston Scientific Corporation
  • Bracco Group
  • Braile Biomedica
  • Direct Flow Medical
  • Edwards Lifesciences
  • Edwards Lifesciences
  • JenaValve
  • Medtronic
  • St. Jude Medical
  • Symetis


Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Transcatheter Heart Valves – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Cardiovascular Diseases and Aging Population Drive Demand for Transcatheter Heart Valve Procedures
Advancements in Valve Design and Delivery Systems Strengthen Business Case for Next-Generation Transcatheter Heart Valves
Growing Preference for Minimally Invasive Cardiac Interventions Expands Addressable Market for Transcatheter Heart Valves in High-Risk Patients
Shift towards Transcatheter Valve-in-Valve (ViV) Procedures Spurs Adoption for Complex and Repeat Interventions
Increasing Use of Transcatheter Aortic Valve Replacement (TAVR) Expands Market Potential in Treating Aortic Stenosis
Rising Adoption of Transcatheter Mitral Valve Replacement (TMVR) Propels Growth in Mitral Regurgitation Treatment
Growing Integration of Imaging and Navigation Technologies Enhances Precision and Success Rates of Transcatheter Valve Procedures
Rising Interest in Personalized and Patient-Specific Heart Valve Solutions Expands Market for Customizable Transcatheter Devices
Focus on Early Detection and Treatment of Heart Valve Disorders Propels Demand for Less Invasive Valve Replacement Solutions
Expanding Application of Transcatheter Heart Valves in Treating Congenital Heart Defects Sustains Market Growth in Pediatric and Adult Congenital Segments
Rising Focus on Expanding Indications Beyond Aortic and Mitral Valves Enhances Market Potential in Treating Tricuspid and Pulmonary Valve Diseases
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve (TAV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Transcatheter Aortic Valve (TAV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Transcatheter Aortic Valve (TAV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Transcatheter Mitral Valve (TMV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Transcatheter Mitral Valve (TMV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Transcatheter Mitral Valve (TMV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Transcatheter Heart Valves Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 11: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Cath lab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Cath lab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Cath lab by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 17: USA Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 18: USA Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: USA 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 20: USA Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 21: USA Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: USA 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
CANADA
TABLE 23: Canada Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 24: Canada Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: Canada 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 26: Canada Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: Canada 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
JAPAN
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 29: Japan Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: Japan Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: Japan 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 32: Japan Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: Japan 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
CHINA
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 35: China Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: China Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: China 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 38: China Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: China Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: China 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
EUROPE
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 41: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 42: Europe Historic Review for Transcatheter Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Europe 16-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 44: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Europe 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
FRANCE
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 50: France Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: France Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: France 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 53: France Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: France Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: France 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
GERMANY
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 56: Germany Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Germany Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Germany 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 59: Germany Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Germany 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
ITALY
TABLE 62: Italy Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Italy Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Italy 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 65: Italy Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Italy 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
UNITED KINGDOM
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 68: UK Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: UK Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: UK 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 71: UK Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: UK Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: UK 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
SPAIN
TABLE 74: Spain Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Spain Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Spain 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 77: Spain Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Spain Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Spain 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
RUSSIA
TABLE 80: Russia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Russia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Russia 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 83: Russia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Russia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Russia 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Rest of Europe Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Rest of Europe 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Rest of Europe 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 93: Asia-Pacific Historic Review for Transcatheter Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Asia-Pacific 16-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Asia-Pacific 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
AUSTRALIA
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 101: Australia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Australia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Australia 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 104: Australia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Australia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Australia 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
INDIA
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 107: India Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: India Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: India 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 110: India Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: India Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: India 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 113: South Korea Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: South Korea Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: South Korea 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 116: South Korea Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: South Korea Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: South Korea 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Rest of Asia-Pacific Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Asia-Pacific Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
LATIN AMERICA
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 125: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 126: Latin America Historic Review for Transcatheter Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Latin America 16-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 128: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Latin America Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Latin America 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 131: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 134: Argentina Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Argentina Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Argentina 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 137: Argentina Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Argentina Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Argentina 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
BRAZIL
TABLE 140: Brazil Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Brazil Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Brazil 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 143: Brazil Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Brazil Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Brazil 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
MEXICO
TABLE 146: Mexico Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Mexico Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Mexico 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 149: Mexico Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Mexico Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Mexico 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Rest of Latin America Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Rest of Latin America 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Rest of Latin America Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Rest of Latin America 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
MIDDLE EAST
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 158: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 159: Middle East Historic Review for Transcatheter Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Middle East 16-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 161: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Middle East Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Middle East 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 164: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
IRAN
TABLE 167: Iran Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Iran Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Iran 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 170: Iran Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Iran Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Iran 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
ISRAEL
TABLE 173: Israel Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: Israel Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Israel 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 176: Israel Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: Israel Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Israel 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Saudi Arabia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Saudi Arabia 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Saudi Arabia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Saudi Arabia 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 185: UAE Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: UAE Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: UAE 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 188: UAE Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: UAE Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: UAE 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Rest of Middle East Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Rest of Middle East 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Rest of Middle East Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Rest of Middle East 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
AFRICA
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 197: Africa Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Africa Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Africa 16-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2014, 2024 & 2030
TABLE 200: Africa Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Africa Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Africa 16-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings